“Fixed-Duration First-Line Therapy for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) in Canada: A Canadian Expert Clinical Framework” (2026) Canadian Hematology Today, 5(s03), pp. 2–16. doi:10.58931/cht.2026.5s0394.